Media

MetaGenoPolis-INRAE is committed alongside major healthcare players in France to accelerate the development of precision medicine.
Coordinated by Imagine Institute and funded with 9,9 million of euros over 5 years, ATRACTion program aims to develop a precision medicine for patients with autoimmune and inflammatory diseases associated with primary immune deficiencies.

MetaGenoPolis-INRAE, center expert in human and animal microbiome research, announces to have been received with other co-investigators new funding from the Aligning Science Across Parkinson’s (ASAP) initiative to investigate the role of the microbiome in phenotypic conversion to Parkinsons disease in a genetically susceptible population. This project, named “Genome-Microbiome Axis in the Cause of Parkinson Disease: Mechanistic Insights and Therapeutic Implications from Experimental Models and a Genetically Stratified Patient Population” will involve the scientific and technical expertise of MetaGenoPolis-INRAE in the field of the microbiome.